Pediatric Atopic Dermatitis (AD) Internet Survey

Wake Forest University (WFU)

Status: Withdrawn

Conditions: Atopic Dermatitis

Treatments: Behavioral: Weekly Internet survey; Drug: Topical Triamcinolone

Study type: Interventional

Funder types: Other

Identifiers

NCT01385527

IRB00016545

Details and patient eligibility

About

The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.

Sex: All

Ages: 2 to 8 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any child age 2 to 8 with a diagnosis of atopic dermatitis confirmed by a dermatologist, together with the child's parent/guardian. Written consent must be given by parent/guardian.

Exclusion criteria

• Child is less than 2 or greater than 8 years of age.
• Known allergy or sensitivity to topical triamcinolone in the child.
• Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access.
• Introduction of any other prescription medication, topical or systemic, for atopic dermatitis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for atopic dermatitis must be on a stable dose for at least 3 months prior to enrollment.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

0 participants in 2 patient groups

Weekly Internet survey w medication

Experimental group

Description:

Weekly survey via email plus topical triamcinolone

Treatment:

Drug: Topical Triamcinolone

Behavioral: Weekly Internet survey

Topical triamcinolone only

Active Comparator group

Description:

Standard of care

Treatment:

Drug: Topical Triamcinolone